• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Diet, gut microbes, and the pathogenesis of inflammatory bowel diseases.饮食、肠道微生物与炎症性肠病的发病机制
Mol Nutr Food Res. 2017 Jan;61(1). doi: 10.1002/mnfr.201600129. Epub 2016 Aug 15.
2
Diet-Microbiota Interactions in Inflammatory Bowel Disease.饮食-微生物群相互作用与炎症性肠病。
Nutrients. 2021 May 1;13(5):1533. doi: 10.3390/nu13051533.
3
Recipe for IBD: can we use food to control inflammatory bowel disease?IBD 食疗:我们能否通过食物控制炎症性肠病?
Semin Immunopathol. 2018 Feb;40(2):145-156. doi: 10.1007/s00281-017-0658-5. Epub 2017 Nov 9.
4
Reciprocal interaction of diet and microbiome in inflammatory bowel diseases.炎症性肠病中饮食与微生物群的相互作用
Curr Opin Gastroenterol. 2015 Nov;31(6):464-70. doi: 10.1097/MOG.0000000000000216.
5
Dietary Composition and Effects in Inflammatory Bowel Disease.饮食构成与炎症性肠病的影响。
Nutrients. 2019 Jun 21;11(6):1398. doi: 10.3390/nu11061398.
6
Microbiota in Inflammatory Bowel Disease Pathogenesis and Therapy: Is It All About Diet?微生物群在炎症性肠病发病机制和治疗中的作用:一切都与饮食有关吗?
Nutr Clin Pract. 2015 Dec;30(6):760-79. doi: 10.1177/0884533615606898. Epub 2015 Oct 9.
7
Bases for the Adequate Development of Nutritional Recommendations for Patients with Inflammatory Bowel Disease.炎症性肠病患者营养建议充分制定的基础。
Nutrients. 2019 May 12;11(5):1062. doi: 10.3390/nu11051062.
8
Pathological and therapeutic interactions between bacteriophages, microbes and the host in inflammatory bowel disease.炎症性肠病中噬菌体、微生物与宿主之间的病理和治疗相互作用。
World J Gastroenterol. 2015 Oct 28;21(40):11321-30. doi: 10.3748/wjg.v21.i40.11321.
9
Diet in the pathogenesis and treatment of inflammatory bowel diseases.饮食在炎症性肠病的发病机制及治疗中的作用
Gastroenterology. 2015 May;148(6):1087-106. doi: 10.1053/j.gastro.2015.01.007. Epub 2015 Jan 15.
10
Diet, Gut Microbiome and Epigenetics: Emerging Links with Inflammatory Bowel Diseases and Prospects for Management and Prevention.饮食、肠道微生物组和表观遗传学:与炎症性肠病的新兴联系及管理和预防的前景。
Nutrients. 2017 Aug 30;9(9):962. doi: 10.3390/nu9090962.

引用本文的文献

1
The crosstalk between host and rumen microbiome in cattle: insights from multi-omics approaches and genome-wide association studies.牛宿主与瘤胃微生物组之间的相互作用:多组学方法和全基因组关联研究的见解
World J Microbiol Biotechnol. 2025 Jul 28;41(8):267. doi: 10.1007/s11274-025-04504-6.
2
Impact of cigarette smoking on gut microbial dysbiosis: a structured literature review.吸烟对肠道微生物失调的影响:一项结构化文献综述
Gut Microbiome (Camb). 2024 May 2;5:e13. doi: 10.1017/gmb.2024.3. eCollection 2024.
3
Unraveling the web of defense: the crucial role of polysaccharides in immunity.揭开防御的面纱:多糖在免疫中的关键作用。
Front Immunol. 2024 Oct 25;15:1406213. doi: 10.3389/fimmu.2024.1406213. eCollection 2024.
4
The Role of Dietary Habits in the Pathogenesis and Development of Inflammatory Bowel Disease: A Narrative Review.饮食习惯在炎症性肠病发病机制及发展中的作用:一篇叙述性综述
Middle East J Dig Dis. 2024 Jan;16(1):5-11. doi: 10.34172/mejdd.2024.362. Epub 2024 Jan 31.
5
The evolutionarily ancient FOXA transcription factors shape the murine gut microbiome via control of epithelial glycosylation.进化上古老的 FOXA 转录因子通过控制上皮细胞糖基化来塑造小鼠肠道微生物组。
Dev Cell. 2024 Aug 19;59(16):2069-2084.e8. doi: 10.1016/j.devcel.2024.05.006. Epub 2024 May 30.
6
Mesenchymal Stromal Cells: New Generation Treatment of Inflammatory Bowel Disease.间充质基质细胞:炎症性肠病的新一代治疗方法
J Inflamm Res. 2024 May 22;17:3307-3334. doi: 10.2147/JIR.S458103. eCollection 2024.
7
Current Knowledge on the Preparation and Benefits of Cruciferous Vegetables as Relates to In Vitro, In Vivo, and Clinical Models of Inflammatory Bowel Disease.十字花科蔬菜的制备及其益处与炎症性肠病的体外、体内和临床模型相关性的当前知识
Curr Dev Nutr. 2024 Apr 17;8(5):102160. doi: 10.1016/j.cdnut.2024.102160. eCollection 2024 May.
8
Emerging Natural Therapies for the Treatment of Inflammatory Bowel Disease.用于治疗炎症性肠病的新兴天然疗法。
Curr Pharm Biotechnol. 2025;26(8):1175-1188. doi: 10.2174/0113892010293150240415143650.
9
Dietary Inflammatory Potential in Pediatric Diseases: A Narrative Review.儿科疾病中的饮食炎症潜能:一项叙述性综述。
Nutrients. 2023 Dec 13;15(24):5095. doi: 10.3390/nu15245095.
10
Optimizing the Gut Microbiota for Individualized Performance Development in Elite Athletes.优化精英运动员个性化表现发展的肠道微生物群。
Biology (Basel). 2023 Dec 5;12(12):1491. doi: 10.3390/biology12121491.

本文引用的文献

1
CARD9 impacts colitis by altering gut microbiota metabolism of tryptophan into aryl hydrocarbon receptor ligands.CARD9通过改变肠道微生物群将色氨酸代谢为芳烃受体配体的过程来影响结肠炎。
Nat Med. 2016 Jun;22(6):598-605. doi: 10.1038/nm.4102. Epub 2016 May 9.
2
How colonization by microbiota in early life shapes the immune system.生命早期微生物群的定殖如何塑造免疫系统。
Science. 2016 Apr 29;352(6285):539-44. doi: 10.1126/science.aad9378.
3
Follow-up of patients with functional bowel symptoms treated with a low FODMAP diet.采用低FODMAP饮食治疗的功能性肠症状患者的随访。
World J Gastroenterol. 2016 Apr 21;22(15):4009-19. doi: 10.3748/wjg.v22.i15.4009.
4
Breastfed at Tiffany's.在蒂芙尼吃母乳。
Trends Biochem Sci. 2016 Jun;41(6):508-518. doi: 10.1016/j.tibs.2016.02.008. Epub 2016 Apr 16.
5
Early Mucosal Healing with Exclusive Enteral Nutrition is Associated with Improved Outcomes in Newly Diagnosed Children with Luminal Crohn's disease.早期黏膜愈合与全肠内营养治疗初诊儿童腔外型克罗恩病的改善结局相关。
J Crohns Colitis. 2016 Oct;10(10):1159-64. doi: 10.1093/ecco-jcc/jjw075. Epub 2016 Mar 15.
6
Fermentable Carbohydrate Restriction (Low FODMAP Diet) in Clinical Practice Improves Functional Gastrointestinal Symptoms in Patients with Inflammatory Bowel Disease.临床实践中限制可发酵碳水化合物(低FODMAP饮食)可改善炎症性肠病患者的功能性胃肠道症状。
Inflamm Bowel Dis. 2016 May;22(5):1129-36. doi: 10.1097/MIB.0000000000000708.
7
Mucosal Healing Is Associated With Improved Long-term Outcomes of Patients With Ulcerative Colitis: A Systematic Review and Meta-analysis.黏膜愈合与溃疡性结肠炎患者的长期预后改善相关:系统评价和荟萃分析。
Clin Gastroenterol Hepatol. 2016 Sep;14(9):1245-1255.e8. doi: 10.1016/j.cgh.2016.01.015. Epub 2016 Jan 30.
8
MicroRNA-124 Promotes Intestinal Inflammation by Targeting Aryl Hydrocarbon Receptor in Crohn's Disease.微小RNA-124通过靶向芳烃受体促进克罗恩病中的肠道炎症
J Crohns Colitis. 2016 Jun;10(6):703-12. doi: 10.1093/ecco-jcc/jjw010. Epub 2016 Jan 22.
9
Aryl hydrocarbon receptor-driven signals inhibit collagen synthesis in the gut.芳基烃受体驱动的信号抑制肠道中的胶原蛋白合成。
Eur J Immunol. 2016 Apr;46(4):1047-57. doi: 10.1002/eji.201445228. Epub 2016 Feb 5.
10
Bile Acid Modifications at the Microbe-Host Interface: Potential for Nutraceutical and Pharmaceutical Interventions in Host Health.在微生物-宿主界面的胆汁酸修饰:营养保健品和药物干预宿主健康的潜力。
Annu Rev Food Sci Technol. 2016;7:313-33. doi: 10.1146/annurev-food-041715-033159. Epub 2016 Jan 11.

饮食、肠道微生物与炎症性肠病的发病机制

Diet, gut microbes, and the pathogenesis of inflammatory bowel diseases.

作者信息

Dolan Kyle T, Chang Eugene B

机构信息

Section of Gastroenterology, Hepatology, and Nutrition, Department of Medicine, The University of Chicago.

出版信息

Mol Nutr Food Res. 2017 Jan;61(1). doi: 10.1002/mnfr.201600129. Epub 2016 Aug 15.

DOI:10.1002/mnfr.201600129
PMID:27346644
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5331923/
Abstract

The rising incidence of inflammatory bowel diseases in recent decades has notably paralleled changing lifestyle habits in Western nations, which are now making their way into more traditional societies. Diet plays a key role in IBD pathogenesis, and there is a growing appreciation that the interaction between diet and microbes in a susceptible person contributes significantly to the onset of disease. In this review, we examine what is known about dietary and microbial factors that promote IBD. We summarize recent findings regarding the effects of diet in IBD epidemiology from prospective population cohort studies, as well as new insights into IBD-associated dysbiosis. Microbial metabolism of dietary components can influence the epithelial barrier and the mucosal immune system, and understanding how these interactions generate or suppress inflammation will be a significant focus of IBD research. Our knowledge of dietary and microbial risk factors for IBD provides important considerations for developing therapeutic approaches through dietary modification or re-shaping the microbiota. We conclude by calling for increased sophistication in designing studies on the role of diet and microbes in IBD pathogenesis and disease resolution in order to accelerate progress in response to the growing challenge posed by these complex disorders.

摘要

近几十年来,炎症性肠病发病率的上升与西方国家生活方式习惯的改变显著平行,而这些生活方式习惯如今正蔓延至更为传统的社会。饮食在炎症性肠病的发病机制中起着关键作用,并且人们越来越认识到,在易感人群中,饮食与微生物之间的相互作用对疾病的发生起着重要作用。在本综述中,我们探讨了已知的促进炎症性肠病的饮食和微生物因素。我们总结了前瞻性人群队列研究中关于饮食对炎症性肠病流行病学影响的最新发现,以及对炎症性肠病相关生态失调的新见解。饮食成分的微生物代谢可影响上皮屏障和黏膜免疫系统,了解这些相互作用如何产生或抑制炎症将是炎症性肠病研究的一个重要重点。我们对炎症性肠病饮食和微生物风险因素的认识为通过饮食调整或重塑微生物群来开发治疗方法提供了重要的考虑因素。我们呼吁在设计关于饮食和微生物在炎症性肠病发病机制和疾病缓解中的作用的研究时提高复杂性,以便应对这些复杂疾病带来的日益严峻的挑战,加速研究进展。